Crossref
Six Sigma driven QC management in hepatitis C serology
Annales de Biologie Clinique · 2024
DOI: 10.1684/abc.2024.1885 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annales de Biologie Clinique, 2024. Verfasst von Mohamed Mokhtar Khelil. Hauptthemen laut MEDLINE: Quality Control, Hepatitis C, Total Quality Management, Serologic Tests.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Quality ControlHepatitis CTotal Quality ManagementSerologic TestsHumansHepatitis C AntibodiesHepacivirusSensitivity and SpecificityReagent Kits, DiagnosticReproducibility of ResultsQuality Assurance, Health CareLaboratories, Clinical
Stichwörter der Autor:innen
QC strategyinfectious diseases serology testssix-sigma
Substanzen
Hepatitis C AntibodiesReagent Kits, Diagnostic
Zitieren
APA
Khelil, M. M. (2024). Six Sigma driven QC management in hepatitis C serology. Annales de Biologie Clinique. https://doi.org/10.1684/abc.2024.1885
Vancouver
Khelil MM. Six Sigma driven QC management in hepatitis C serology. Annales de Biologie Clinique. 2024. doi:10.1684/abc.2024.1885
BibTeX
@article{Khelil2024,
author = {Khelil, Mohamed Mokhtar},
title = {Six Sigma driven QC management in hepatitis C serology},
journal = {Annales de Biologie Clinique},
year = {2024},
doi = {10.1684/abc.2024.1885}
}
EUVIMED